Retroperıtoneal Soft-Tıssue Sarcomas

Retroperitoneal Sarcoma Clinical Trial

Official title:

Retroperıtoneal Soft-Tıssue Sarcomas: Retrospectıve Clınıcal Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05044624
• Other study ID #: IMU2021
• Status: Completed
• Phase: N/A
• Start date: March 1, 2016
• Est. completion date: June 1, 2021

Study information

• Verified date: September 2021
• Source: Istanbul Medeniyet University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

: Soft Tissue Sarcomas are rare mesenchymal tumors with many subtypes. Clean margin-wide resection is recommended for treatment. The guidelines recommend that sarcoma treatments be carried out in sarcoma centers. In this study, the location, histopathological features, clinical and demographic features, recurrence, and prognosis of retroperitoneal sarcomas were investigated.

Description:

The demographic, histopathological, and immunohistochemical data of the patients who were operated on with the diagnosis of intraabdominal mass at Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital from March 2016 to December 2020 were retrospectively evaluated. Ethical approval was obtained from Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital Ethics Committee.

Patients diagnosed with pathological sarcoma subclass were included in the study. Patients younger than 18 years were excluded from the study. Visceral organ-origin sarcomas and extremity sarcomas were also excluded from the study. GIST's were included in sarcoma subtypes by WHO in 2013. However, they were not included in the study due to their solid organ origin.

The data of 18 patients' whore remained after the exclusion criteria were analyzed retrospectively. Pathology samples of the patients were re-examined by a single pathologist.

The demographic analysis was used for statistics.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 18
• Est. completion date: June 1, 2021
• Est. primary completion date: June 1, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients operated with the diagnosis of intra-abdominal mass

• patients diagnosed with pathological sarcoma subclasses

Exclusion Criteria:

• Patients younger than 18 years

• Visceral organ-origin sarcomas

• extremity sarcomas

• GIST

Related Conditions & MeSH terms

• Margin, Tumor-Free
• Retroperitoneal Sarcoma
• Sarcoma

Intervention

Procedure:
• retroperitoneal mass excision
retroperitoneal mass excision

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul Medeniyet University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Clean margin wide resection	effect of clean surgical margin on recurrence	63 month